Real-world experience with cefiderocol therapy for <i>Pseudomonas aeruginosa</i> and other multidrug resistant gram-negative infections within the Veterans Health Administration, 2019-2022.

Chou, Andrew; Ramsey, David; Amenta, Eva; Trautner, Barbara W

Real-world experience with cefiderocol therapy for Pseudomonas aeruginosa and other multidrug resistant gram-negative infections within the Veterans Health Administration, 2019-2022.

Chou, Andrew; Ramsey, David; Amenta, Eva; Trautner, Barbara W.

Afiliação

Chou A; Michael E. DeBakey, Veterans' Affairs Medical Center, Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Houston, Texas.
Ramsey D; Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, Texas.
Amenta E; Michael E. DeBakey, Veterans' Affairs Medical Center, Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Houston, Texas.
Trautner BW; Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas.

Antimicrob Steward Healthc Epidemiol ; 3(1): e90, 2023.

Article em En | MEDLINE | ID: mdl-37179761

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article